Preclinical data suggest good tolerability, but rigorous human safety work is limited
This flexibility makes injectable BPC-157 practical for addressing multiple concerns simultaneously
BPC-157 side effects are relatively uncommon, but may include nausea, diarrhea, and dizziness
BPC 157 application was always combined with the application of the NOS-blocker L-NAME (NOS-blockade), and NOS-substrate, L-arginine (NO-system over-activity), given alone and/or together (L-NAME (NO-system blockade), and L-arginine (NO-system-over-activity), combined L-NAME+L-arginine (NO-system immobilization)
Perform tests
However, many over-the-counter (OTC) products make claims that are not well supported by research